Drugs / CDR2
last change Mar 2007 re-read 3 minutes ago

CDR2

Developed for
eye accommodation disease
Investigated by
Ryogoku Eye Clinic

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00877201 Mar 2007 → ? eye accommodation disease Ryogoku Eye Clinic Completed Met primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CDR2 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00877201 ↗